The DSM 5 Website Proposals for Somatic Symptom Disorder: Three Central Problems

2012 ◽  
Vol 53 (6) ◽  
pp. 524-531 ◽  
Author(s):  
Richard Sykes
2014 ◽  
Vol 11 (03) ◽  
pp. 149-155
Author(s):  
M. Zaudig

ZusammenfassungDer vorliegende Artikel beschreibt die aktuellen diagnostischen Entwicklungen im Bereich der Somatoformen Störung unter Zugrundelegung der aktuellen S3-Leitlinien für „Nichtspezifische funktionelle und somatoforme Körperbeschwerden“ und der historischen Entwicklung der Somatoformen Störungen (einschließlich der Hypochondrie). Neben einem Vergleich von ICD-10 mit DSM-IV-TR und DSM-5 werden die neuen Kriterien für Somatic Symptom Disorder und Illness Anxiety Disorder (vormals Hypochondrie) nach DSM-5 vorgestellt und diskutiert.


2016 ◽  
Vol 209 (5) ◽  
pp. 407-413 ◽  
Author(s):  
Erik Hedman ◽  
Erland Axelsson ◽  
Erik Andersson ◽  
Mats Lekander ◽  
Brjánn Ljótsson

BackgroundIn DSM-5 two new diagnoses, somatic symptom disorder (SSD) and illness anxiety disorder (IAD), have replaced DSM-IV hypochondriasis. There are no previous treatment studies for these disorders. Cognitive–behavioural therapy (CBT) delivered as therapist-guided or unguided internet treatment or as unguided bibliotherapy could be used to increase treatment accessibility.AimsTo investigate the effect of CBT delivered as guided internet treatment (ICBT), unguided internet treatment (U-ICBT) and as unguided bibliotherapy.MethodA randomised controlled trial (RCT) where participants (n= 132) with a diagnosis of SSD or IAD were randomised to ICBT, U-ICBT, bibliotherapy or to a control condition on a waiting list (trial registration: Clinicaltrials.gov identifier NCT01966705).ResultsCompared with the control condition, all three treatment groups made large and significant improvements on the primary outcome Health Anxiety Inventory (between-groupdat post-treatment was 0.80–1.27).ConclusionsICBT, U-ICBT and bibliotherapy can be highly effective in the treatment of SSD and IAD. This is the first study showing that these new DSM-5 disorders can be effectively treated.


2021 ◽  
pp. 1-17
Author(s):  
Bernd Löwe ◽  
James Levenson ◽  
Miriam Depping ◽  
Paul Hüsing ◽  
Sebastian Kohlmann ◽  
...  

Abstract Background In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This review aims to comprehensively synthesize contemporary evidence related to SSD. Methods A scoping review was conducted using PubMed, PsycINFO, and Cochrane Library. The main inclusion criteria were SSD and publication in the English language between 01/2009 and 05/2020. Systematic search terms also included subheadings for the DSM-5 text sections; i.e., diagnostic features, prevalence, development and course, risk and prognostic factors, culture, gender, suicide risk, functional consequences, differential diagnosis, and comorbidity. Results Eight hundred and eighty-two articles were identified, of which 59 full texts were included for analysis. Empirical evidence supports the reliability, validity, and clinical utility of SSD diagnostic criteria, but the further specification of the psychological SSD B-criteria criteria seems necessary. General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5–13.3%], while prevalence studies based on criterion standard interviews are lacking. SSD was associated with increased functional impairment, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Relevant research gaps remain regarding developmental aspects, risk and prognostic factors, suicide risk as well as culture- and gender-associated issues. Conclusions Strengths of the SSD diagnosis are its good reliability, validity, and clinical utility, which substantially improved on its predecessors. SSD characterizes a specific patient population that is significantly impaired both physically and psychologically. However, substantial research gaps exist, e.g., regarding SSD prevalence assessed with criterion standard diagnostic interviews.


2017 ◽  
Author(s):  
Stephen Thielke

Somatic symptom disorder (SSD) is a novel construct, first presented in the DSM-5. It has two criteria: distressing or impairing bodily symptoms and excessive or disproportionate thoughts, feelings, or behaviors directed toward those symptoms. The criteria must be applied critically to make sense logically and clinically. The framework does not suggest any causal relationship between the elements. SSD uses a different formulation than in previous constructs, with no requirement that symptoms be medically unexplained. Little research has been conducted about SSD, and it is inappropriate to draw conclusions from similar diagnoses. Therefore, almost nothing is known about epidemiology, natural history, and treatment response in SSD. Health anxiety disorder is similar to SSD, but without significant somatic symptoms. Conversion disorder and factitious disorder entail more specific findings than does SSD. Providers should carefully apply diagnostic criteria for SSD, focus on the individual’s distress, and consider how this diagnosis influences the provider-patient relationship. Future research will refine the understanding of the condition and therapeutic approaches to it. This review contains 1 figure, 5 tables, and 39 references. Key words: behaviors, conversion disorder, disproportionate, excessive, factitious disorder, feelings, health anxiety, somatic symptom disorder, somatization, thoughts


2017 ◽  
Vol 77 ◽  
pp. 1-11 ◽  
Author(s):  
Karina Limburg ◽  
Heribert Sattel ◽  
Andreas Dinkel ◽  
Katharina Radziej ◽  
Sandra Becker-Bense ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document